L&C Bio has completed a successful webinar on its ECM-based skin booster Rejuve for over 200 Myanmar doctors, signaling growing demand for advanced regenerative aesthetics in Southeast Asia. The event focused on clinical protocols for Rejuve and Rejuve Fine, highlighting the product's unique human acellular dermal matrix (hADM) technology.
Webinar highlights
The webinar, titled 'The ECM Revolution Begins,' featured Dr. Shin Dong-woo of Nabi Plastic Surgery as the speaker and Dr. Su Phyo Aung of Clinique de Skin Dermatology & Laser Clinic in Yangon as the moderator. Dr. Shin shared practical injection techniques using the I-ject B device, covering periorbital, neck wrinkle, and under-eye applications.
Product differentiation
Rejuve is positioned as the world's first ECM-based skin booster using hADM. Unlike conventional collagen-stimulating products, it restores depleted ECM components and promotes skin regeneration, targeting pore size, texture, density, and pigmentation. This positions it as a next-generation skin rejuvenation solution for aesthetic clinics.
Market signal
More than 200 Myanmar physicians attended, with an extended Q&A session lasting over 30 minutes. The strong engagement indicates rising interest in ECM-based regenerative treatments in the Southeast Asian market. L&C Bio plans to expand academic exchanges with global medical professionals to strengthen Rejuve's regional presence.
What buyers should watch
Distributors and clinic buyers in Southeast Asia should monitor L&C Bio's expanding educational initiatives and regulatory progress for Rejuve. The product's ECM restoration mechanism and device-assisted injection protocol may offer a differentiated offering for clinics seeking advanced skin booster portfolios.
Source: Read the original report | Published: June 11, 2026